Home pageCRL • NYSE
add
Charles River Laboratories International, Inc.
199,48 $
After Hours:(0,00%)0,00
199,48 $
Data e ora chiusura: 31 dic, 16:49:01 GMT-5 · USD · NYSE · Disclaimer
Chiusura precedente
201,98 $
Intervallo giornaliero
199,45 $ - 202,53 $
Intervallo annuale
91,86 $ - 205,00 $
Cap di mercato
9,82 Mld USD
Volume medio
744,48K
Rapporto P/E
-
Dividendo/Prezzo
-
Borsa valori principale
NYSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Entrate | 1,00 Mld | -0,49% |
Spese di gestione | 201,05 Mln | -8,50% |
Utile netto | 54,42 Mln | -21,87% |
Margine di profitto netto | 5,42 | -21,45% |
Utili per azione | 2,43 | -6,18% |
EBITDA | 165,25 Mln | -30,05% |
Aliquota fiscale effettiva | 36,29% | — |
Stato patrimoniale
Totale attivo
Totale passivo
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Investimenti cash/breve termine | 207,10 Mln | -1,46% |
Totale attivo | 7,51 Mld | -6,12% |
Totale passivo | 4,06 Mld | -2,71% |
Patrimonio netto totale | 3,45 Mld | — |
Azioni in circolazione | 49,22 Mln | — |
Prezzo/valore contabile | 2,92 | — |
Redditività dell'attivo | 5,01% | — |
Rendimento sul capitale | 6,16% | — |
Flusso di cassa
Flusso di cassa netto
| (USD) | set 2025info | Variazione Y/Y |
|---|---|---|
Utile netto | 54,42 Mln | -21,87% |
Liquidità di esercizio | 213,83 Mln | -15,08% |
Contanti da investimenti | -33,70 Mln | -58,02% |
Contanti da finanziamenti | -152,62 Mln | 26,46% |
Flusso di cassa netto | 24,48 Mln | -20,09% |
Flusso di cassa libero | 60,91 Mln | -72,72% |
Informazioni
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Fondazione
1947
Sito web
Dipendenti
19.400